In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Align gets $18.2mm in private financing

Executive Summary

Align Technology (orthodontic devices) sold 9.58mm shares priced at $1.90 each (a 22% premium based on the 10-day market average), raising $18.2mm in a private placement led by the Carlyle Group. Also participating were Kleiner Perkins Caufield & Byers, Gund Investment Corp., Oak Hill Capital Partners, and private investors.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register